FIELD: pharmaceutical industry. SUBSTANCE: strain Streptomyces resistomycificus is cultivated in liquid culture medium. Desired materials WS 7622 A, B, C or D or their pharmaceutically available salts are then isolated of culture medium. EFFECT: improves efficiency of method. 12 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| WS-7622A DISULFATES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2087482C1 |
| METHOD OF SYNTHESIS OF COMPOUND "WS7622A" DERIVATIVES | 1990 |
|
RU2021280C1 |
| PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1992 |
|
RU2043365C1 |
| METHOD OF SYNTHESIS OF ALKANESULFONANILIDE DERIVATIVES OR THEIRS PHARMACEUTICALLY ACCEPTABLE SALTS | 1988 |
|
RU2012557C1 |
| METHOD OF SYNTHESIS OF PEPTIDES WS-9326A DERIVATIVES | 0 |
|
SU1826970A3 |
| OCTANE OXASPIRO [2,5]DERIVATIVE AND PROCESS FOR PREPARATION THEREOF (VARIANTS) | 1989 |
|
RU2068412C1 |
| ANTIBIOTIC COMPOSITION | 1988 |
|
RU2029549C1 |
| METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1990 |
|
RU2021990C1 |
| CEPHEM COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1992 |
|
RU2081874C1 |
| HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS | 1994 |
|
RU2176640C2 |
